TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
6.78
-0.10 (-1.45%)
Sep 11, 2026, 2:05 PM CST

TaiwanJ Pharmaceuticals Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---22.7415.3622.06
Revenue Growth
---48.11%-30.38%-
Gross Profit
---22.74-59.9222.06
Operating Income
-21.29-25.21-26.96-6.61-96.39-9.73
Net Income
-18.35-24.34-22.34-6.05-92.47-12.42
Earnings Per Share
-0.23-0.30-0.29-0.08-1.23-0.17
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
60.1767.8287.6158.8360.6982.88
Total Debt
2.071.790.471.171.860.33
Net Cash (Debt)
58.166.0487.1457.6658.8382.55
Net Cash Growth
-12.02%-24.21%51.12%-1.99%-28.73%-10.81%
Net Cash Per Share
0.730.821.140.770.781.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.47-24.17-22.62-0.82-21.07-10.05
Capital Expenditures
--0.29--1.44-1.23-
Free Cash Flow
-19.47-24.46-22.62-2.26-22.3-10.05
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%-100.00%
Operating Margin
----29.07%-627.77%-44.09%
Pretax Margin
----16.59%-602.19%-46.77%
Profit Margin
----26.59%-602.20%-56.32%
FCF Margin
----9.95%-145.22%-45.56%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---48.7251.8634.41